White-light toxicity, resulting from systemically administered 5-aminolevulinic acid, under normal operating conditions.
This study has investigated damage to the intraperitoneal organs of the rat after systemic (intraperitoneal and intravenous) administration of low doses of 5-aminolevulinic acid (ALA) and illumination with a standard white-light operating-room (o.r.) lamp. The study has been done within the framework of a larger study in which the possibility of using ALA for localization of small-volume macroscopically nonvisible peritoneal metastasis of ovarian tumors is being investigated. Fluorescence diagnostics are done in addition to the standard staging and localization procedures, either through a laparoscope or during laparotomy. In these circumstances, fluorescence diagnostics involve some risk of photosensitization of critical organs since a broad-band (o.r.) light source is used during the surgical procedures for illumination of the operating area. The drug dose and the time interval between administration of ALA and illumination are varied and normal tissues are examined both macroscopically and microscopically for damage. A relationship is demonstrated between the maximum tolerable dose (MTD) of ALA (defined as the dose that does not cause any tissue damage) and the time interval between administration and illumination. The white light that is used for illumination of the operating area is sufficient to induce damage to the peritoneal organs at relatively low ALA doses. The MDTs for 2, 6 and 16 h intervals are found to be respectively 1, 10 and 100 mg kg-1. The results are similar for both intraperitoneal and intravenous administration.
Aalders
M C
MC
Laser Centre, Academic Medical Centre, Amsterdam, The Netherlands.
vd Vange
N
N
Stewart
F A
FA
Klein
M G
MG
vd Vijver
M J
MJ
Sterenborg
H J
HJ
D000622:Aminolevulinic Acid / Q000494:pharmacology*; D000818:Animals; D005260:Female; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D007421:Intestine, Small / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D008027:Light / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D020714:Maximum Tolerated Dose; D010529:Peritoneal Cavity / Q000528:radiation effects*; D051381:Rats; D017208:Rats, Wistar
D000622:Aminolevulinic Acid